1. NIH 'very concerned' about serious side effect in coronavirus vaccine trial  FiercePharma
  2. Global report: Covid cases near 30m as China expects vaccine as soon as November  The Guardian
  3. Latest on worldwide spread of coronavirus  Armidale Express
  4. Nobody wants vaccine trials to fail. But they just might.  The Washington Post
  5. COVID-19: UAE vaccine strengthens fight against coronavirus | Editorials  Gulf News
  6. View Full coverage on Google News
While the FDA weighs whether to resume its trial of AstraZeneca's COVID-19 vaccine, which triggered a clinical hold last week after a U.K. patient was hit with a serious side effect, the NIH has launched its own study into the reaction—which could take up to two months to wrap, one NIH officer said.While the FDA weighs whether to resume its trial of AstraZeneca's COVID-19 vaccine, which triggered a clinical hold last week after a U.K. patient was hit with a serious side effect, the NIH has launched its own study into the reaction—which could take up to two months to wrap, one NIH officer said.

NIH 'very concerned' about serious side effect in coronavirus vaccine trial | FiercePharma

Coronavirus deaths pass 925,000; biosafety head at Chinese CDC says vaccine progress ‘very smooth’; South Korea to secure early vaccines for 30 millionCoronavirus deaths pass 925,000; biosafety head at Chinese CDC says vaccine progress ‘very smooth’; South Korea to secure early vaccines for 30 million

Global report: Covid cases near 30m as China expects vaccine as soon as November | Coronavirus outbreak | The Guardian

Reuters with a curious report - Pfizer has more than 29,000 people in its 44,000-volunteer trial - testing their experimental COVID-19 vaccine What? for (not very much) more By Eamonn SheridanReuters with a curious report - Pfizer has more than 29,000 people in its 44,000-volunteer trial - testing their experimental COVID-19 vaccine What? for (not very much) more

Pfizer trial participants showing side effects when given either experimental coronavirus vaccine or placebo

DEATHS AND INFECTIONS EUROPE * Britain's testing system for COVID-19 is creaking as a bottleneck prevents people including medics getting a test, with the gov...DEATHS AND INFECTIONS EUROPE * Britain's testing system for COVID-19 is creaking as a bottleneck prevents people including medics getting a test, with the gov...

Latest on worldwide spread of coronavirus | The Armidale Express | Armidale, NSW

US regulators have not allowed AstraZeneca's vaccine trial to resume in America and first want to determine if the jab or another factor caused a UK participant to suffer spinal cord inflammation.US regulators have not allowed AstraZeneca's vaccine trial to resume in America and first want to determine if the jab or another factor caused a UK participant to suffer spinal cord inflammation.

US regulators are 'very concerned' about the side effects of AstraZeneca's vaccine | Daily Mail Online

Products often don't make it through Phase 3 trials. Covid-19 vaccines are no different.Products often don't make it through Phase 3 trials. Covid-19 vaccines are no different.

Opinion | Nobody wants vaccine trials to fail. But they just might. - The Washington Post

Gulf News Zero Campaign aims to raise awareness to help the country flatten the curveGulf News Zero Campaign aims to raise awareness to help the country flatten the curve

COVID-19: UAE vaccine strengthens fight against coronavirus | Editorials – Gulf News

Mary Kate Rylands discusses the power dynamics surrounding the search for a Covid-19 vaccine.

Power, populism and cooperation: the politicisation of vaccines | Palatinate Online

The drugmaker's CEO said there was a more than 60% chance that they would know by the end of next month if BNT162b2 is effective.The drugmaker's CEO said there was a more than 60% chance that they would know by the end of next month if BNT162b2 is effective.

Pfizer says it could know if its COVID-19 vaccine candidate works in October // Motley Fool Australia

egypttoday,Politics,Business,Economy,Art,culture,Local news,Special interest,Press Review,News,ResourcesHead of the Russian Direct Investment Fund Kirill Dmitriev said Tuesday that Egypt is one of Russia’s main partners in the region.

Egypt to be gate for "Sputnik V" vaccine to Africa: Russian official - Egypt Today

Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.

Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare: investigator | Reuters

The number of confirmed cases of the coronavirus that causes COVID-19 edged closer to 30 million on Tuesday, as a Chinese health official said a vaccine may...The number of confirmed cases of the coronavirus that causes COVID-19 edged closer to 30 million on Tuesday, as a Chinese health official said a vaccine may...

Coronavirus update: Global cases edge toward 30 million, and China says vaccine may be ready by November - MarketWatch

China's COVID-19 vaccine could be ready for public in November: expert - CGTN

Trials of AstraZeneca Covid-19 vaccine remain on hold until midweekTrials of AstraZeneca Covid-19 vaccine remain on hold until midweek

Coronavirus: Global infections approach 30 million

In August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India. As part of the expanded agreement, Serum Institute will also manufactureIn August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India. As part of the expanded agreement, Serum Institute will also manufacture

Novavax aims for 2 billion COVID-19 vaccine doses with expanded India deal

Recon: AstraZeneca resumes COVID vaccine trials in South Africa, Brazil, US study still on hold | RAPS

The United Arab Emirates (UAE) on Monday granted emergency approval for use of a coronavirus vaccine developed in China, six weeks after human trials on the vaccine started in the country.

UAE approves urgent use of China-developed COVID-19 vaccine after test on 31,000 volunteers - Global Times

Through this agreement, Indonesia could ensure access to COVAXs COVID-19 vaccines once they were available, Foreign Minister Retno Marsudi said.Through this agreement, Indonesia could ensure access to COVAX's COVID-19 vaccines once they were available, Foreign Minister Retno Marsudi said.

Indonesia, UNICEF sign agreement on COVID-19 vaccine procurement under COVAX Facility - World - The Jakarta Post

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science, Technology, Health & Fitness news & opinions from leading columnists.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Over 300 volunteers have been inoculated during the post-registration trials of Russia's COVID-19 vaccine, dubbed Sputnik V, around 14 percent of them have reported fatigue, muscle pain or high body temperature, Russian Health Minister Mikhail Murashko said on Tuesday. "Over 300 persons have been vaccinated.

Over 300 Volunteers Get Russian COVID-19 Vaccine - Novinite.com - Sofia News Agency

British scientists are beginning a small study comparing how two experimental coronavirus vaccines might work when they are inhaled by people instead of being injected.British scientists are beginning a small study comparing how two experimental coronavirus vaccines might work when they are inhaled by people instead of being injected.

The magazine’s Ethicist columnist on whether participating in a vaccine trial means you can act as if you’re part of an “immune elite” — and more.The magazine’s Ethicist columnist on whether participating in a vaccine trial means you can act as if you’re part of an “immune elite” — and more.

403 - Forbidden: Access is denied.

The country has four Covid-19 vaccines in the final stage of clinical trials.The country has four Covid-19 vaccines in the final stage of clinical trials.

China coronavirus vaccine may be ready for public in November: official - World - DAWN.COM

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.

Researchers trial inhaled versions of Oxford and Imperial Covid-19 vaccine candidates - world news - Hindustan Times

Experts send formal letter to Lancet outlining doubts about efficacy of vaccineExperts send formal letter to Lancet outlining doubts about efficacy of vaccine

15 scientists launch critique of Russia’s COVID-19 vaccine data | Europe – Gulf News

Experts call the global response to the COVID-19 pandemic a "collective failure."Experts call the global response to the COVID-19 pandemic a "collective failure."

Pandemic total passes 29 million as cases hit daily high | CIDRAP

Southeast Asian nation to get anti-toxin through COVAX Facility mechanism - Anadolu AgencySoutheast Asian nation to get anti-toxin through COVAX Facility mechanism - Anadolu Agency

Indonesia, UN join hands for access to COVID-19 vaccine

The vaccine trial remains on hold pending a US FDA investigation into a serious side effect in the UK - sources. The vaccine trial remains on hold pending a US FDA investigation into a serious side effect in the UK - sources.

AstraZeneca COVID-19 vaccine trial in US remains on hold | News | Al Jazeera

The World Health Organization has provided details on a potential rollout for a COVID-19 vaccine.

World Health Organization announces distribution plan for COVID-19 vaccine

Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, surmised that if we are able to bring a safe and effective vaccine to market by the end of 2020, it will still likely be late into 2021 before we are able to do once normal things, like going to a theater and comfortably not wearing a mask. Here’s everything else you need to know this week.Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, surmised that if we are able to bring a safe and effective vaccine to market by the end of 2020, it will still likely be late into 2021 before we are able to do once normal things, like going to a theater and comfortably not wearing a mask. Here’s everything else you need to know this week.

AstraZeneca resumed its COVID-19 vaccine trials after uncovering a mysterious reaction | Popular Science

Pfizer Inc said on Tuesday participants were showing mostly mild-to-moderate side effects when given either the company's experimental coronavirus vaccine or a placebo in an ongoing late-stage study. The company said in a presentation to investors that side effects included fatigue, headache, chills and muscle pain. Some participants in the trial also developed fevers -Pfizer Inc said on Tuesday participants were showing mostly mild-to-moderate side effects when given either the company's experimental coronavirus vaccine or a placebo in an ongoing late-stage study.

Pfizer says coronavirus vaccine study shows mostly mild-to-moderate side effects | Deccan Herald

“The complications are described in the instructions and are predictable,” Russia's health minister said.“The complications are described in the instructions and are predictable,” Russia's health minister said.

1 in 7 Russian Coronavirus Vaccine Volunteers Report Side Effects - The Moscow Times

A China-developed vaccine could be ready for the public as early as November, the chief biosafety expert at the Chinese Centre for Disease Control tells state broadcaster CCTV.A China-developed vaccine could be ready for the public as early as November, the chief biosafety expert at the Chinese Centre for Disease Control tells state broadcaster CCTV.

Covid-19 wrap | Germany seeks herd immunity by mid-2021 and Dublin pubs remain closed | News24

50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...

Russian Direct Investment Fund CEO Stresses Tech Based on Monkey Adenoviral Vectors 'Yet Unproven' - Sputnik International

About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.

14% of volunteers testing pioneering Russian Covid-19 vaccine ‘Sputnik V’ have experienced side effects, health ministry says — RT Russia & Former Soviet Union

UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been releasedUK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been released

Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency - Scientific American

Emergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures - ZAWYA MENA EditionEmergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures

The Korea Herald is South Korea’s largest English-language daily and the country’s sole member of the Asia News Network (ANN). The Korea Herald is South Korea’s largest English-language daily and the country’s sole member of the Asia News Network (ANN).

The Korea Herald

Open letter flags results that appear to be duplicated and calls for access to the underlying data on the first COVID-19 vaccine to be approved for widespread use. Open letter flags results that appear to be duplicated and calls for access to the underlying data on the first COVID-19 vaccine to be approved for widespread use.Open letter flags results that appear to be duplicated and calls for access to the underlying data on the first COVID-19 vaccine to be approved for widespread use.

Researchers highlight ‘questionable’ data in Russian coronavirus vaccine trial results

The Serum Institute of India (SII) had got the green signal from the DGCI to restart the re-enrollment procedure for COVID-19 vaccine which is being developed by AstraZeneca and Oxford University following the recommendations made by Data Safety Monitoring Board (DSMB) .The Serum Institute of India (SII) had got the green signal from the DGCI to restart the re-enrollment procedure for COVID-19 vaccine which is being developed by AstraZeneca and Oxford University following the recommendations made by Data Safety Monitoring Board (DSMB) .

Serum Institute Of India Gets DCGI's Green Signal To Resume Phase 2-3 Trials For Oxford-AstraZeneca Covid-19 Vaccine

“We don’t have all facts, so we don’t know the causation per se of this, but we really need to look into it," FDA Commissioner Stephen Hahn said.“We don’t have all facts, so we don’t know the causation per se of this, but we really need to look into it," FDA Commissioner Stephen Hahn said.